Your browser doesn't support javascript.
loading
A systematic review and meta-analysis of observational studies of the association between the use of incretin-based therapies and the risk of pancreatic cancer.
Hidayat, Khemayanto; Zhou, Ying-Yi; Du, Hong-Zhen; Qin, Li-Qiang; Shi, Bi-Min; Li, Zeng-Ning.
Afiliación
  • Hidayat K; Department of Endocrinology and Metabolism, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Zhou YY; Department of Nutrition and Food Hygiene, School of Public Health, Soochow University, Suzhou, China.
  • Du HZ; Department of Endocrinology and Metabolism, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Qin LQ; Department of Nutrition, The First Hospital of Hebei Medical University, Hebei Province Key Laboratory of Nutrition, Shijiazhuang, China.
  • Shi BM; Department of Nutrition and Food Hygiene, School of Public Health, Soochow University, Suzhou, China.
  • Li ZN; Department of Endocrinology and Metabolism, The First Affiliated Hospital of Soochow University, Suzhou, China.
Pharmacoepidemiol Drug Saf ; 32(2): 107-125, 2023 Feb.
Article en En | MEDLINE | ID: mdl-36224724

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Inhibidores de la Dipeptidil-Peptidasa IV Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Pharmacoepidemiol Drug Saf Asunto de la revista: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Inhibidores de la Dipeptidil-Peptidasa IV Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Pharmacoepidemiol Drug Saf Asunto de la revista: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido